Humacyte Inc (HUMA) Stock Price, Quote & News

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 919-313-9633

Website: humacyte.com

Address:

2525 East North Carolina Highway 54, Durham, United States

JuniperLuna Jul. 14 at 1:28 AM

$HUMA

0 · Reply

SteelerJon Jul. 13 at 9:17 PM

$HUMA 😎🏦🏦 Know what you own.

1 · Reply

SteelerJon Jul. 13 at 9:16 PM

$HUMA Looks like the future is bright! 😎🏦🏦 Google: AI Overview According to 8 Wall Street analysts, the consensus average price target for Humanigen (HUMA) is $11.71. The current price for HUMA is $2.31. The analyst ratings are a "Buy" consensus with: 1 hold rating 6 buy ratings 1 strong buy rating The highest price target for HUMA is $25.00, and the lowest is $4.00. The average price target of $11.71 indicates a potential upside of 407.11% from the current price.

0 · Reply

Runmaster83 Jul. 13 at 8:36 PM

$HUMA

0 · Reply

N2Deeeep Jul. 13 at 6:23 PM

$HUMA SPAC Scam! Going to zero!

2 · Reply

TheYoungGeologist Jul. 12 at 8:57 PM

$HUMA it will be a real bummer if positive NTAP news is muted and overshadowed by tariffs on Aug 1

3 · Reply

Phillvsthemarket Jul. 12 at 7:40 AM

$HUMA Puerto Rico folks are looking for my man as we speak in PA Nobody will mess up with my money 😡

2 · Reply

BaileyZippy Jul. 12 at 12:34 AM

$HUMA we get approved to sell to the DoD and not a word out of Laura. Dougan didn't buy another house or go golfing. I guess Laura doesn't expect to sell them even one unit. I guess Huma hasn't sold many since last quarter. What did we sell less than 20 units?!?! Nice transparency from the CEO.

1 · Reply

LuckEtradER Jul. 11 at 11:57 PM

$HUMA

0 · Reply

AXL888 Jul. 11 at 9:20 PM

$HUMA please guys, is it ever possible to see this sheisse going to $3.50 again?

1 · Reply

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Jun 11, 2025, 9:05 AM EDT - 4 weeks ago

Humacyte: Revenue Ramp From Symvess Incoming

Jun 9, 2025, 8:00 AM EDT - 4 weeks ago

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Jun 2, 2025, 8:00 AM EDT - 5 weeks ago

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

May 19, 2025, 4:05 PM EDT - 7 weeks ago

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

May 13, 2025, 2:29 PM EDT - 2 months ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:30 AM EDT - 2 months ago

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

May 9, 2025, 8:00 AM EDT - 2 months ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Mar 28, 2025, 1:48 PM EDT - 3 months ago

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Mar 28, 2025, 7:30 AM EDT - 3 months ago

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Mar 26, 2025, 8:00 AM EDT - 3 months ago

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Mar 25, 2025, 8:35 PM EDT - 3 months ago

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Mar 25, 2025, 4:01 PM EDT - 3 months ago

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Mar 10, 2025, 8:00 AM EDT - 4 months ago

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Mar 6, 2025, 8:00 AM EST - 4 months ago

Trestle Bio Announces Research Collaboration with Humacyte

Mar 3, 2025, 8:00 AM EST - 4 months ago

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Feb 27, 2025, 4:05 PM EST - 4 months ago

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 4 months ago

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Feb 26, 2025, 8:00 AM EST - 4 months ago

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Feb 20, 2025, 1:35 PM EST - 5 months ago

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Jan 21, 2025, 8:00 AM EST - 6 months ago

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Jan 17, 2025, 10:30 AM EST - 6 months ago

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Jan 9, 2025, 5:45 AM EST - 6 months ago

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

Jan 2, 2025, 8:15 AM EST - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

JuniperLuna Jul. 14 at 1:28 AM

$HUMA

0 · Reply

SteelerJon Jul. 13 at 9:17 PM

$HUMA 😎🏦🏦 Know what you own.

1 · Reply

SteelerJon Jul. 13 at 9:16 PM

0 · Reply

Runmaster83 Jul. 13 at 8:36 PM

$HUMA

0 · Reply

N2Deeeep Jul. 13 at 6:23 PM

$HUMA SPAC Scam! Going to zero!

2 · Reply

TheYoungGeologist Jul. 12 at 8:57 PM

$HUMA it will be a real bummer if positive NTAP news is muted and overshadowed by tariffs on Aug 1

3 · Reply

Phillvsthemarket Jul. 12 at 7:40 AM

$HUMA Puerto Rico folks are looking for my man as we speak in PA Nobody will mess up with my money 😡

2 · Reply

BaileyZippy Jul. 12 at 12:34 AM

1 · Reply

LuckEtradER Jul. 11 at 11:57 PM

$HUMA

0 · Reply

AXL888 Jul. 11 at 9:20 PM

$HUMA please guys, is it ever possible to see this sheisse going to $3.50 again?

1 · Reply

PeteyRob Jul. 11 at 9:19 PM

$HUMA our new bestie, Dr. Roberto, is the only person who gave Hooman's post a thumbs up. Shocking . 😂🤣😂🤣 Also, I had a bunch of new people view my profile, including medical professionals and a person from the Humacyte sales team. We see you, Dr. Roberto. 😘

7 · Reply

Runmaster83 Jul. 11 at 9:15 PM

$HUMA My genuine question is how could a venerated New York Times “Reporter” get a one-sided article published without including an alternative perspective by Humacyte or anyone who was actually involved in the approval process? This is why people no longer trust the news or FDA. A 10th grader with a B average could do a better job researching the good Dr. and his business/financial conflicts.

3 · Reply

Druean Jul. 11 at 9:12 PM

$HUMA False inuendos 🤣🤣🤣

0 · Reply

pgixhunter Jul. 11 at 9:11 PM

$HUMA Love seeing y'all putting Robert on blast rofl

0 · Reply

Phillvsthemarket Jul. 11 at 8:36 PM

$HUMA wait what is going on ?

1 · Reply

Phillvsthemarket Jul. 11 at 8:36 PM

$HUMA I love it

0 · Reply

Doctor_C_MD Jul. 11 at 8:20 PM

$HUMA Oh this is good, you guys got him engaged, we have to deliver the knock out blow now

1 · Reply

JinwooBuffett Jul. 11 at 8:17 PM

$HUMA Exactly 3 weeks from today, CMS will publish their final rule at 5 PM. If you want to see for yourself whether Symvess got NTAP approved, navigate to the CMS 2026 final rule home page and scroll down to “MAC Implementation File 8”. This zip file contains the list of newly approved NTAP submissions. or you can wait until Humacyte issues a press release shortly after 🤷🏾‍♂️

2 · Reply

JinwooBuffett Jul. 11 at 8:11 PM

$HUMA I’m laughing out loud. Y’all got him pressed.

3 · Reply

Doctor_C_MD Jul. 11 at 8:08 PM

$HUMA LOL, did you guys organize a takedown of Dr. Lee on his LinkedIn page today?

1 · Reply

EV_Alpha_Invest Jul. 11 at 8:05 PM

$HUMA Fucking 8%

0 · Reply

Doctor_C_MD Jul. 11 at 8:04 PM

$HUMA Why is this stuff coming up again? Are the dirt bags writing more bogus articles?

0 · Reply

Market Cap	358.33M
Revenue (ttm)	0.00
Net Income (ttm)	-148.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	4,230,400
Avg Vol	4,342,352
Day's Range	N/A - N/A
Shares Out	155.12M
Stochastic %K	32%
Beta	1.89
Analysts	Strong Sell
Price Target	$9.43